CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.
about
In vitro correlates of HIV-2-mediated HIV-1 protectionMolecular cloning, sequence, expression, and processing of the interleukin 16 precursorHuman immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causationPathogenesis of human immunodeficiency virus infectionVirus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infectionTemporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndromeT helper cell activation and human retroviral pathogenesisDEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypesSELDI ProteinChip® Array Technology: Protein-Based Predictive Medicine and Drug Discovery ApplicationsBiologically-directed modeling reflects cytolytic clearance of SIV-infected cells in vivo in macaquesCD8 T cell response maturation defined by anentropic specificity and repertoire depth correlates with SIVΔnef-induced protectionTCR affinity associated with functional differences between dominant and subdominant SIV epitope-specific CD8+ T cells in Mamu-A*01+ rhesus monkeysViral CTL escape mutants are generated in lymph nodes and subsequently become fixed in plasma and rectal mucosa during acute SIV infection of macaquesHIV and the chemokine system: 10 years later.Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 regionCellular immune selection with hepatitis C virus persistence in humansAn epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans.Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like proteinHIV-1 antiviral activity of recombinant natural killer cell enhancing factors, NKEF-A and NKEF-B, members of the peroxiredoxin familyEffect of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine on establishment of human immunodeficiency virus type 1 infection in cultured CD8+ lymphocytesComparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cellsProgress in HIV vaccine research.Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?CD8(+)T-cell-mediated control of HIV-1 and SIV infection.Evolutionary dynamics of HIV at multiple spatial and temporal scales.HIV-1 Vaccine Trials: Evolving Concepts and DesignsSoluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNases.CD8(+) T-cell effector function and transcriptional regulation during HIV pathogenesisAutocrine production of beta-chemokines protects CMV-Specific CD4 T cells from HIV infectionCD8+ cell-derived anti-human immunodeficiency virus inhibitory factor.Cytopathic effect of human immunodeficiency virus in T4 cells is linked to the last stage of virus infection.CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells.In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells.Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys.Alpha-defensins inhibit HIV infection of macrophages through upregulation of CC-chemokines.Laureate ESCI award for excellence in clinical science 1999. Cytokines and the human immunodeficiency virus: from bench to bedside. European Society for Clinical Investigation.Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression.Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival.Inhibition of simian immunodeficiency virus (SIV) replication by CD8(+) T lymphocytes from macaques immunized with live attenuated SIVVaccine protection against a heterologous, non-syncytium-inducing, primary human immunodeficiency virus.
P2860
Q22254217-19BF0EB5-48F8-42D4-8EA1-D74EF7AF9FE3Q24319776-10B7545D-0CD9-4A30-B86E-74D47A5D13E6Q24627627-F2BD4AAE-9801-4A79-AE1D-1CBBBAB6F92FQ24634681-FA8B4D69-CD84-4B2B-9C03-03FFDCE01353Q24645815-5CBDB0CD-EF41-40C2-BDC2-606778AA38E0Q24648628-EFA27321-6D83-4359-A743-0BF5A8866379Q24650854-6B784EA7-153B-4F31-8659-7376C0C5A9ADQ24682603-50E3A269-43E9-4C55-98A6-272DFE78670DQ24800590-EDC032AB-0468-4A65-B412-1B2B4953E3D5Q27319762-DE347339-D368-402B-838A-A61F407650CFQ27321448-2859AB44-ED78-4582-B4DA-84AF3C167E1DQ27329011-8B517238-4FAD-4866-B4C2-3A3374E4A21BQ27349889-12B225C4-CA63-4514-BF63-693C322D2464Q27473020-9FEAA8B7-7073-41BA-A957-4A4A87AAF60BQ27480326-F749A589-3332-470B-A2AE-E4B41657FEABQ27485219-65580784-A89C-4A68-889A-BBEE6F5E7408Q27485984-38E4B118-C1B2-4BDA-9151-45F7DDA220CAQ27486239-4250C7A2-F357-464A-BF81-CEDFF56119C9Q28214202-01C1DB3D-7F00-4476-B210-D929FE4F1BAFQ28369395-502BA56A-CA70-4E0F-8537-C9A2AE1380FBQ28378786-59A66BDB-1E0D-4B36-8ABA-D7953717CFABQ30331429-812FA4A8-EBAA-4BCA-9C7A-B25E21228F9EQ30362489-6E7DBAAB-8943-4017-B4B6-BC864DF24FF4Q30397667-71CE4C7D-BD41-4F07-B6EE-68779A681420Q30416280-1BD7075A-A5F2-46F7-8805-1281C585E13EQ30425520-BD7A0200-FF2D-4194-AB3A-952B67EA74AFQ30427403-23E94798-0CBA-47C8-AAA3-79E0D434FB55Q30432007-DFE55647-C60B-4A23-9B09-BCE483068AC9Q33513965-ACCB9BD7-6CEB-415E-8930-A2BC88F32FD5Q33547164-872E2104-2915-480E-B663-75F1FAF1DAFFQ33575253-D2D0CA2E-D657-4CF6-A8B7-85CCD232729FQ33618007-A975BE20-EE6E-43D7-AC35-1BA2881EFA58Q33618013-0EE138A0-C3A5-422F-8492-2D1359681DF0Q33642024-F383B17E-F972-47BB-96F9-08409B2A63C7Q33669536-690CED4B-FC57-4F89-9C64-A66BE189DAFFQ33717470-AAE9246B-76B0-47BA-B691-D31EBDA7C0AEQ33747965-E9780CED-6720-46D6-8BB9-C48624FF649FQ33759097-CB370791-B6F3-4655-99B7-4F3609D01C2CQ33783155-90FC6461-B2D6-4371-89D0-8AAB12BCC3DFQ33786386-05C8B9EF-F7A1-4327-A9DC-9E21925F0FF4
P2860
CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.
description
1986 nî lūn-bûn
@nan
1986 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.
@ast
CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.
@en
CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.
@nl
type
label
CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.
@ast
CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.
@en
CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.
@nl
prefLabel
CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.
@ast
CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.
@en
CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.
@nl
P2093
P356
P1433
P1476
CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.
@en
P2093
P304
P356
10.1126/SCIENCE.2431484
P407
P577
1986-12-01T00:00:00Z